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Abstract
Viral loads were investigated in SIVmnd-1 chronically infected mandrills and the results were compared with those previously observed
in other nonpathogenic natural SIV infections. Four naturally and 11 experimentally SIVmnd-1-infected mandrills from a semi-free-ranging
colony were studied during the chronic phase of infection. Four SIVmnd-1-infected wild mandrills were also included for comparison.
Twelve uninfected mandrills were used as controls. Viral loads in all chronically infected mandrills ranged from 105 to 9  105 copies/ml
and antibody titers ranged from 200 to 14,400 and 200 to 12,800 for anti-V3 and anti-gp36, respectively. There were no differences between
groups of wild and captive mandrills. Both parameters were stable during the follow-up, and no clinical signs of immune suppression were
observed. Chronic SIVmnd-1-infected mandrills presented slight increases in CD20 and CD28/CD8 cell counts, and a slight decrease
in CD4/CD3 cell counts. A slight CD4/CD3 cell depletion was also observed in old uninfected controls. Similar to other
nonpathogenic models of lentiviral infection, these results show a persistent high level of SIVmnd-1 replication during chronic infection of
mandrills, with minimal effects on T cell subpopulations.
© 2003 Elsevier Inc. All rights reserved.
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Introduction
More than 30 simian immunodeficiency viruses (SIVs)
naturally infect nonhuman African primates (Apetrei et al.,
2004). Their overall seroprevalence in the wild is very high
(estimated 18–30%) (Jolly et al., 1996; Chen et al., 1996;
Souquiere et al., 2001; Peeters et al., 2002). Although they
were named SIV because of their structural and biological
resemblance to the human immunodeficiency virus (HIV),
SIV infections are mostly nonpathogenic in their natural
hosts (Beer et al., 1998; Rey-Cuille et al., 1998; Diop et al.,
2000; Goldstein et al., 2000; Broussard et al., 2001; Silvestri
et al., 2003). A few exceptions have been documented in
mandrills and African green monkeys (Pandrea et al., 2001;
Souquiere et al., 2001; Traina-Dorge et al., 1992). Disease
is probably a rare consequence because of long-term adap-
tation of SIV to its natural African primate hosts, which is
reflected in continuous and sustained viral replication with
minimal effects on immune function (Kaur et al., 1998;
Silvestri et al., 2003).
There is evidence showing that SIVs have pathogenic
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potential. Cross-species transmission of SIVsm to macaques
results in increased pathogenicity and induction of simian
acquired immunedeficiency syndrome (sAIDS) (Letvin et
al., 1985; Murphey-Corb et al., 1986). HIV-1 and HIV-2,
which have simian origins, are responsible for the AIDS
pandemic (Peeters et al., 1989; Gao et al., 1999; Chen et al.,
1996). Experimental transmission of SIVagm from African
green monkeys (AGMs) and SIVIhoest from I’hoesti mon-
keys to pig-tailed macaques has also shown pathogenic
potential and immunosuppression (Hirsch et al., 1995,
1999). In these cases, high viral loads induce massive acti-
vation and destruction of the immune system (Alimonti et
al., 2003). Therefore, plasma viral load is considered the
best predictor of the clinical outcome in humans and ma-
caques (Mellors et al., 1996; Lifson et al., 1997).
In this study, we have investigated the relationship be-
tween SIV and its natural host in a new model, SIVmnd-1
chronic infection of mandrills. The probable origin of
SIVmnd-1 was reported to be from Cercopithecus lhoesti
solatus to mandrills (Hirsch et al., 1999; Beer et al., 1999).
This observation raised the question as to whether or not
mandrills should be considered as long-term natural hosts of
SIVmnd-1 and whether the course of infection would be the
same as in other nonpathogenic infections. The preponder-
ance of evidence indicates that mandrills are a natural host
because recent studies have shown that SIVmnd-1 is highly
prevalent in wild mandrills, suggesting that cross-species
transmission was an ancient event and that the virus infects
this species naturally (Souquiere et al., 2001). SIVmnd-1
replicates to high levels during experimental primary infec-
tion in mandrills and this replication has only slight and
transitory effects on the dynamics of immune cells (Onanga
et al., 2002). This pattern is very similar to those observed
during the primary infection of other nonhuman primate
species (Diop et al., 2000; Kaur et al., 1998).
Here we address the hypothesis as to whether or not
mandrills represent an intermediate level between patho-
genic and nonpathogenic SIV infections or whether or not
the virus is adapted to the mandrill host. Only one
SIVmnd-1 strain (GB-1) is available and it was adapted in
vitro and reported to use CXCR4 as the main coreceptor,
which is highly unusual for SIV (Schols and De Clerq,
1998; Beer et al., 2001). Therefore, SIVmnd-1 (GB-1) may
have a higher pathogenic potential compared to SIVs which
use CCR-5 as the major coreceptor (Marx and Chen, 1998).
However, SIVmnd-1 GB1 recovered during the primary
infection used CCR5 and Bonzo and not CXCR4 (R.
Onanga, unpublished observation).
As chronic infection reflects the long-term natural his-
tory of SIV, the aim of the present study was to measure the
dynamics of RNA plasma viral load, anti-SIVmnd-1 anti-
body titers, and lymphocyte subsets in mandrills chronically
infected with SIVmnd-1 to compare these data with those
previously observed in other nonpathogenic models. Data
from wild mandrills are also presented for comparison.
Results
Clinical and immunological follow-up of chronically
infected SIVmnd-1 mandrills
No clinical signs of AIDS were observed during annual
follow-ups of chronically, naturally infected mandrills
(17B, 17D, 17G, 17D2) in captivity. Eleven experimentally
infected animals (n  11) were examined every 3 months.
No follow-up was possible for the wild mandrills, but all
were clinically normal at the time of sampling.
Viral load quantification in experimentally infected
mandrills
In HIV-infected humans and SIV-infected rhesus ma-
caques the quantification of plasma viral RNA provides a
measure of the magnitude of virus replication (Mellors et
al., 1997; Lifson et al., 1997). For viral RNA loads in
plasma, a QC-RT-PCR assay specific for SIVmnd-1 was
developed (Onanga et al., 2002) using primers MP5/MP6
from a conserved region in integrase of SIVmnd-1 GB-1
(Nerrienet et al., 1998). There were no mismatches (Onanga
et al., 2002). Our previous studies on the acute phase of
SIVmnd-1 infection showed that high viral loads obtained
by QC-RT-PCR directly correlated with both p24 Ag titers
and plasma RT activity (Onanga et al., 2002).
Experimentally infected mandrills included in this study
were mandrills from a primary infection experiment (12A4,
2C2, 10G, 12C2) inoculated intravenously (iv) with 3000
TCID50, and dams in a breastfeeding transmission experi-
ment (5I, 5J, 12A3, 12A7, 6B, 16C), which received 300
TCID50 iv of the same stock. Mandrill 16E received 10 ml
of blood from the mandrill naturally infected with GB-1
(F17). This virus was titered at 4 TCID50 on SupT1 cells, a
value which corresponded to 896,000 RNA copies/ml
(Onanga et al., 2002). In experimentally infected mandrills,
the viral set point was reached between days 30 and 60
postchallenge (Onanga et al., 2002). In this present study we
quantified the SIVmnd-1 RNA loads in 19 samples col-
lected between days 180 and 540 postchallenge from all 11
experimentally infected mandrills (Table 1). SIVmnd-1
plasma viral loads are presented in Table 1. Although results
obtained at days 180 and 360 for mandrills 12A4, 16E, 2C2,
and 10G have been presented elsewhere, these points are
also showed in Table 1 for comparison. Viral RNA levels
ranged from 18,000 to 334,000 copies/ml, similar to the
range observed in SIVsm-infected sooty mangabeys (Rey-
Couille et al., 1998; Ling et al., 2003; Silvestri et al., 2003)
and AGMs (Goldstein et al., 2000; Broussard et al., 2001;
Holzammer et al., 2001). No statistically significant differ-
ence was observed in viral loads of mandrills in different
cohorts. Moreover, viral loads observed during the acute
phase of SIVmnd-1 infection had no differences with re-
spect to the infectious dose (Onanga et al., 2002; Pandrea et
al., 2002).
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Viral loads in captive naturally infected mandrills
Serial sampling during a 15-year seroepidemiological
follow-up of mandrills in the semifree ranging CIRMF
colony has shown a cluster of SIVmnd-1 infections in a
founder female mandrill F17 (GB1), three of her offspring
(F17B, F17D, and M17G), and two of the F17D offspring
(17D1 and 17D2). Dynamics of plasma SIVmnd-1 load in
the founder female F17 (GB1) over a 15-year period have
been published elsewhere (Pandrea et al., 2001). Here we
present the dynamics of SIVmnd-1 plasma load on serial
samples originating from four mandrills. F17B was born in
1987 and five sequential samples were tested (Table 1).
QC-RT-PCR showed a remarkably narrow range of viral
loads (93,750 copies/ml) in all but one sample. The remain-
ing sample was stored at 20°C and was used for antibody
testing. Both anti-V3 and anti-gp36 antibody titers were
stable during the follow-up: 1/4800 and 1/6400, respec-
tively. F17D was born in 1992 and three samples were
tested. SIVmnd-1 viral loads for mandrill F17D were sim-
ilar to F17B (93,750 copies/ml). However, antibody titers
for F17D were significantly lower than for 17B (Table 1).
Only one plasma sample was tested from the remaining
animals. Mandrill 17D2 was born in 1997 and had been
sampled once in 2000. Its viral load was significantly higher
than observed in other mandrills (289,235 copies/ml) and
antibody titers were significantly lower than those of 17B,
but similar to those of 17D. The remaining mandrill (M17G)
was born in 1996. His plasma viral load from 2000 was the
highest in this study group (892,338 copies/ml). Anti-
SIVmnd-1 antibody titers were low in this mandrill as well
(Table 1).
Table 1
SIVmnd-1 plasma viral load quantification (QC-RT-PCR) and antibody titers in experimentally infected, chronic naturally infected, and wild mandrills
Experimentally infected
captive mandrills
Day PIa Copies/ml anti-V3 anti-gp41
12A4 D180 334,000 800 400
D360 93,750 1600 800
D540 93,750 4800 800
16E D180 150,000 400 400
D360 93,750 1600 800
D540 93,750 4800 800
2C2 D180 93,750 400 400
D360 66,964 1600 800
D540 93,750 4800 800
10G D180 66,964 1600 400
D360 66,964 4800 1600
D540 18,750 14,400 3200
12C2 D180 66,964 1600 400
5I D180 155,000 800 450
5J D180 66,964 1600 400
12A3 D180 40,000 200 200
12A7 D180 334,821 400 450
6B D150 334,821 1600 450
16C D180 334,821 800 800
Naturally infected captive
mandrills
Year Copies/ml anti-V3 anti-gp41
17B 1992 93,750 4800 6400
1993 93,750 4800 6400
1995 93,750 4800 12,800
1999 ND 4800 6400
2000 93,750 4800 6400
17D 1993 ND 0 200
1999 93,750 400 800
2000 93,750 1600 1600
17D2 2000 289,235 1600 800
17G 2000 892,338 800 200
Wild mandrills Year Copies/ml anti-V3 anti-gp41
MS22-Lope 2001 334,821 1600 1600
MS23-Lope 2001 206,596 1600 400
MS25-Lope 2001 66,964 1600 800
MS21-Lope 2001 66,964 800 400
a P.I.  postinoculation.
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Feral mandrills
Previous reports of SIVmnd prevalence in mandrills
were limited to SIVmnd-2 infections, which has a larger
geographical distribution (Takehisha et al., 2001; Peeters et
al., 2002). However, recent data originating from ecological
and seroepidemiological studies have shown that SIVmnd-1
is readily transmitted in the wild, as 10 of 14 mandrills
sampled in the Lope reserve in Gabon harbored SIVmnd-1
(Souquiere et al., 2001). In 2001, seven wild mandrills from
the Lope reserve were sampled. Four were positive for
SIVmnd-1 RNA. The two major aims of viral quantification
in these mandrills were (1) to compare with results observed
in the CIRMF colony in both naturally and experimentally
infected mandrills, and (2) to determine if a high SIVmnd-1
prevalence in feral mandrills correlated with high viral
loads. The results are presented in Table 1. All four wild
mandrills harbored SIVmnd-1 viral loads in the same range
as the captive mandrills (7  104–3  105 copies/ml), and
also in the same range as African green monkeys and sooty
mangabeys (Broussard et al., 2001; Goldstein et al., 2000;
Holzammer et al., 2001; Chrakrabarti et al., 2000a; Silvestri
et al., 2003). These results indicate that our primers were
suitable for SIVmnd-1 quantification, as divergent viruses
were amplified and viral loads were similar to experimen-
tally inoculated animals.
Flow cytometry
Lymphocyte subsets (expressed as median and 25–75th
percentile) were investigated in eight of the experimentally
infected mandrills. Twelve uninfected mandrills served as
controls. These mandrills were either age-matched (n  6)
or old mandrills, aged over 18 years (range 18–23 years) (n
 6). This last group was examined to determine if an
age-related decline of CD4 cells occurs in mandrills, similar
to that reported in SIVsm-uninfected sooty mangabeys
(Chakrabarti et al., 2000a, 2000b) and humans (Mo et al.,
2003).
When the haematological parameters (expressed as me-
dian and 25–75th percentile) of chronically infected (n  8,
mean age 8.6 years, range 3–19 years) and uninfected (n 
6) age-matched (mean age 8.2 years, range 4–12) monkeys
were analyzed by the Mann–Whitney test, no significant
difference was noted in absolute lymphocyte counts be-
tween the two groups, expressed as103 cells/l blood (5.2
 1.6 versus 4.63  2.32, in SIVmnd-1-infected and non-
infected mandrills, respectively). However, the absolute
CD20, CD3, and CD8 counts were higher in the in-
fected animals.
Higher absolute CD8 T cell numbers were found in the
infected monkeys compared to age-matched uninfected
mandrills (2230  1310 cells/l blood versus 1871  1160
cells/l blood, P  0.05). Similar data were observed in
relative values of CD8 cells, which were higher in infected
mandrills (mean: 52.39%, range: 39.4–62.5%) compared to
young age-matched uninfected mandrills (mean: 45.63%;
range: 35.3–58.2%) (Fig. 1). The effect of age was ex-
pressed by a slight decrease in total lymphocyte in old
uninfected controls. Thus, mean absolute lymphocyte
counts, expressed as 103 cells/l blood, were 3.92  1.2
in old uninfected mandrills, which was similar to that pre-
viously reported in old sooty mangabeys (Chakrabarti et al.,
2000b). Mean percentages of CD8 cells in old uninfected
mandrills was 40.1% (range: 30.1  51.7%).
CD3 cells were also higher in SIVmnd-1-infected man-
drills (Fig. 1a), but this difference was not statistically
significant between the three groups.
Differences were observed in the expression of activa-
tion markers when two groups of animals, SIVmnd-1-in-
fected versus uninfected, were compared (Fig. 1b). CD8
Fig. 1. (a) Box-plots of the relative numbers of lymphocyte subsets in
mandrills. The plots correspond to young age-matched uninfected man-
drills (mean 7.9 years, range 6–11 years) (); old uninfected mandrills
(mean 18.6 years; range: 17–22 years) ( ); and SIVmnd-1-infected man-
drills (mean 7.4 years; range 3–12 years) (). (b) Activation status of
CD4 and CD8 cells in young age-matched SIVmnd-1 uninfected ( and
infected () mandrills, as determined by HLA-DR and/or CD28 coexpres-
sion. In the box plots representation, the box extends from the 25th
percentile to the 75th percentile, with a horizontal line at the median, and
the dots extend down to the smallest value and up to the largest value.
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HLA-DR cells were increased in infected mandrills
(mean: 7%, range: 6.1–10.2) compared to age-matched un-
infected controls (mean: 5.51%, range: 3.2–7.1). CD8
CD28 cells were also higher in infected mandrills (mean:
17.81%, range: 14.5–21.5%) compared to uninfected con-
trols (mean: 15.55%, range: 13.2–18.7%). No difference in
activation markers were detected on CD4 cells between
infected and uninfected mandrills (Fig. 1b).
In summary, minor differences were detected between
infected and uninfected mandrills, mostly within the CD3
and CD8 cells, and activation status in the latter. However,
these differences were not statistically significant.
Discussion
In this study the viral load in SIVmnd-1 chronically
infected mandrills was investigated. Although previous re-
ports measured viral loads in captive African monkeys
(Goldstein et al., 2000; Broussard et al., 2001; Chakrabarti
et al., 2000a; Ling et al., 2003; Silvestri et al., 2003), to our
knowledge, this is the first report describing SIV viral loads
in wild natural infected hosts. The only other study which
investigated the viral burden in wild sooty mangabeys mea-
sured only cellular proviral loads and not plasma RNA
(Chen et al., 1996). No significant differences were ob-
served in viral loads of mandrills from experimentally and
naturally infected study groups. Chronic viral loads were
also similar in animals receiving different infectious doses
of SIVmnd-1, showing that dose had no detectable influence
on the dynamics of acute (Onanga et al., 2002; Pandrea et
al., 2002) or chronic SIVmnd-1 infection. A potential lim-
itation of our study as a model of the natural history of the
SIVmnd-1 infections is that all experimentally infected an-
imals received the same viral strain (SIVmnd-1 GB1). How-
ever, this is also true of SIV pathogenesis studies in rhesus
macaques, which are infected with very similar SIVmac
strains (Mansfield et al., 1995). Our results showed that
experimental infection reproduced similar patterns of virus-
host dynamics as observed in naturally infected mandrills.
Viral loads described here in wild mandrills were in the
same range as those reported by others examining sooty
mangabeys and AGMs (Rey-Cuille et al., 1998; Diop et al.,
2000; Goldstein et al., 2000; Broussard et al., 2001; Ling et
al., 2003; Silvestri et al., 2003). The fact that viral loads are
the same between wild and captive mandrills indicates that
diet, medical care, and other factors play little role in de-
termining viral load. Conversely, these latter factors plus a
lack of natural predators and not a lower viral replication are
likely to be responsible for the longer life span of captive
monkeys compared to wild ones.
Although the sequences of SIVmnd-1 strains from wild
mandrills have been not analyzed in this study, previous
analysis has shown significant viral diversity in SIVmnd-1-
infected mandrills from the Lope reserve (Souquiere et al.,
2001). However, our primers were designed from a highly
conserved region of the SIVmnd-1 genome and therefore
are likely to correctly amplify divergent SIVmnd-1 strains.
In humans, HIV-1 viral diversity may significantly influ-
ence the performances of different commercially available
viral load quantification kits. Thus, bDNA designed to map
the polymerase region has a better sensitivity than gag-
based Monitor–Roche for the quantification of divergent
HIV-1 group M viruses, which may vary in up to 20% of pol
sequences (Damond et al., 1999). Our strategy of amplify-
ing the integrase region seems more appropriate for the
quantification of divergent viruses than a gag-based strat-
egy. However, in a recent study of viral loads in sooty
mangabeys from the Yerkes National Primate Research
Centre, gag quantification gave similar results with a UTR-
based method for the quantification of SIVsm [Silvestri et
al., 2003), despite the cocirculation in the Yerkes colony of
four different SIVsm lineages (Ling et al., 2003; A. Kaur, C.
Apetrei, and P.A. Marx, unpublished observation).
It is not clear why the prevalence of SIVmnd-1 in man-
drils from the Lope reserve is higher than generally reported
for other natural SIV infection (Jolly et al., 1996, Peeters et
al., 2002). Since no differences were detected in viral loads
between wild and captive mandrills, the differences in prev-
alence between different groups of the same species or
different nonhuman primate species may not be related to
virological or host factors but rather to behavior which
favors viral transmission (Santiago et al., 2003). SIV might
be concentrated in specific nonhuman primate populations
rather than widely distributed. This is also consistent with
the hypothesis that lentivirus transmission to humans only
occurred in relatively limited areas in Central and West
Africa (Peeters et al., 2002).
In humans and macaques there is a strong correlation
between the pattern of viral replication and the clinical
course of infection, a high viral load often predicting early
disease (Mellors et al., 1997; Lifson et al., 1997). Previous
reports suggested that the lack of pathogenicity of nonhu-
man primate lentiviruses in their natural hosts might be due
to low viral replication (Hartung et al., 1992). However,
several subsequent studies as well as this study have shown
that during the chronic phase of infection, primate lentivi-
ruses replicate at moderate to high levels without clinical or
pathological signs (Rey-Couille et al., 1998; Diop et al.,
2000; Goldstein et al., 2000; Broussard et al., 2001; Hol-
zammer et al., 2001). Therefore the lack of pathogenicity of
SIVs, including SIVmnd-1, cannot be explained by limited
replication in their natural host.
Anti-gp36 and anti-V3 antibody titers were performed to
evaluate antibody responses and relationship to virus load.
The immunodominant region of the gp36 is one of the most
conserved SIV epitopes and it is useful in diagnostic tests in
both humans and nonhuman primates. Detecting anti-gp36
antibodies is a very effective diagnostic tool (Simon et al.,
2001). Although in HIV-1 infection V3 region of gp120 is
highly variable, this region is significantly more conserved
in SIV infection (Franchini et al., 1990). This is supported
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by the finding that all the infected mandrills tested so far
reacted with GB-1 V3 peptide. Our SIVmnd-1 V3 peptide is
able to even detect antibodies in SIVmnd-2-infected man-
drills or SIVdrl-infected drills (Souquiere et al., 2001; Si-
mon et al., 2001). This is not surprising, as SIVmnd-2 and
SIVdrl are recombinant viruses with a SIVmnd-1 envelope
(Souquiere et al., 2001; Hu et al., 2003). The anti-V3 anti-
bodies were tested because a decrease in titers is often
correlated with disease progression and a decline in serum
neutralizing activity in HIV-1-infected humans (Fenouillet
et al., 1995). We have also reported a loss of anti-V3
antibodies in an SIVmnd-1-infected mandrill with immune
suppression (Pandrea et al., 2001). However, none of the
mandrills presented here showed decreased anti-V3 titers.
Also, there was no clear correlation between viral load and
anti-V3 titers. Theoretically, a more meaningful gauge of
immune function and its relationship to viral load may have
been neutralizing antibody responses. However, SIVmnd-1
GB1 grows poorly in cell culture, and this has hampered a
proper evaluation of neutralizing antibody responses. Also,
it should be noted that in other SIV naturally infected
African monkeys, neutralizing antibody responses are gen-
erally low (Apetrei et al., 2004).
From a clinical point of view, African monkeys may be
similar to long-term nonprogressing HIV-infected humans.
It was suggested that SIV adaptation to the nonprogressor
status may be due to induction of a persistent infection with
a symptom-free period exceeding the normal life span of
most monkeys (Pandrea et al., 2001). However, in African
nonhuman primates infected with SIV, the pathologic
mechanisms must be different from those observed in HIV-
1-infected long-term nonprogressors, in whom the low
HIV-1 loads are due to active cellular immune responses
(Cao et al., 1995). In contrast, African monkeys have high
viral loads which are associated with an attenuated antiviral
cellular immune response (Chakrabarti et al., 2000a; Holz-
nagel et al., 2002; Silvestri et al., 2003). Moreover, this
equilibrium is maintained for long periods of time, without
any clinical and immunological sign of immune suppres-
sion. Thus, our analysis of immunophenotypic markers in
SIVmnd-1-infected mandrills was designed to determine if
high levels of viremia have any effect on T cells. None of
the parameters included in our immunophenotypic analysis
showed significant differences between SIVmnd-1-infected
and uninfected mandrills. Chronically infected mandrills
were found to maintain relatively normal CD4 counts in
peripheral blood, despite years of infection. The slight in-
crease in levels of CD8 HLA-DR cells observed in
chronically infected mandrills was not associated with de-
creased levels of CD8 CD28 cells, unlike results ob-
served in humans (Giorgi et al., 1999; Sousa et al., 2002).
However, this data are similar to data previously reported in
SIVsm-infected sooty mangabeys (Silvestri et al., 2003).
Our results indicate that SIVmnd-1 is well adapted to its
mandrill host, and that cross-species transmission of lenti-
viruses in the wild can be controlled by the new primate
host. The mechanism(s) of this resistance to SIV of African
monkeys should be further investigated to gain insights to
control HIV infection.
Materials and methods
Animals
A total of 19 SIVmnd-1 chronically infected mandrills
were examined, 4 of which resided in a large semi-free
enclosure, and were naturally infected in captivity. Further-
more, these four (17B, 17D, 17D2, 17G) were offspring of
the founder SIVmnd-1 GB1 female with whom they were
raised/housed, suggesting that vertical transmission oc-
curred. However, serial plasma samples were only exam-
ined on two of these mandrills: F17B (1992, 1993, 1995,
1999, and 2000) and F17D (1993, 1999, and 2000).
Eleven mandrills were experimentally infected in two
different experiments: mandrills 16E, 2C2, 12A4, 10G,
12C2 were intravenously infected with 3000 TCID50. Data
on acute infection in these animals have been published
elsewhere (Onanga et al., 2002). Mandrills 12A3, 16C,
12A7, 5I, 5J, 6B were infected intravenously with 300
TCID50 SIVmnd-1 and viral loads were measured (day
180). In both experiments, the inoculum was derived from
plasma prepared as previously described (Onanga et al.,
2002). An additional 11 uninfected mandrills were used as
controls for flow cytometry analyses. In the study group, 5
animals were male (2C2, 12A4, 17G, 12C2, 10G) and 10
were female (17B, 17D, 17D2, 12A3, 16C, 16E, 12A7, 5I,
5J, 6B). The mean age of the animals was 8.6 (range 3–19).
The mean weight for the males was 30 kg and 15 kg for
females. Mandrill 12C2 died in 2000 of gastric dilatation,
with no evidence of AIDS (Onanga et al., 2002). The wild
mandrills originated from the Lope reserve in Central Ga-
bon. All were adult solitary males in good health at the time
of capture. No follow-up was possible for these mandrills
because they were released.
Sampling
Animals were anesthetized with ketamine–HCl and 7–10
ml of whole blood was collected in EDTA. Plasma was
separated and stored at 80°C until used for semiquantita-
tive viral load analysis and serology. Whole blood was used
for flow cytometry as described below.
Quantification of viral RNA in plasma
RNA quantification was performed by a limiting-dilution
RT-PCR assay specific for SIVmnd-1 (Onanaga et al.,
2002). The primers were MP5 (5-CCA GAT AAG TGG
AAG ATA GAA AAG-3) and MP6 (5-GGG AGA TAT
GGG AAG ATT GGG-3), allowing the amplification of a
476-bp region within the SIVmnd-1 GB1 pol gene as pre-
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viously described (Nerrienet et al., 1998). Since the virus
used in this study was derived from the SIVmnd-1 GB1, the
possibility of mismatches was minimal.
RNA was extracted from plasma using the QIAamp
Viral RNA Mini kit (Qiagen, Courtaboeuf, France). The
RNA extracted from 540 l of plasma was subjected to
seven 5- to 10-fold serial dilutions which were used for the
RT-PCR (one step RT-PCR kit, Qiagen). Reverse transcrip-
tion was performed at 50°C for 30 min in the presence of
MP5 and MP6, followed by 47 cycles of 95°C for 15 s,
55°C for 45 s, and 72°C for 1 min, with a final extension of
7 min at 72°C. The absolute target copy numbers were
determined by amplification in parallel of known amounts
of a SIVmnd-1 RNA external standard. The standard was
obtained by amplifying the 476-bp region of SIVmnd-1
GB1 pol from F17 genomic DNA. The PCR product was
cloned into the pCR 2.1 vector using the topoTA Cloning
Kit (Invitrogen, Groningen, The Netherlands). The 5-3
sense orientation of the insert was verified by sequence
analyses. A clone containing the insert in 5-3 orientation
was chosen and subjected to PCR using the primer pair
pCRT7S 5 (GCG TAA TAC GAC TCA CTA TAG GGA
GAG GA GCTC GAG CGG CCG CCA GTG TG) and
pCRT7AS (5-ATT ACG CCA AGC TTG GTA CCG AG-
3), which hybridize to regions just upstream and down-
stream of the pCR2.1 plasmid polylinker sequence. Cycling
conditions for this PCR consisted of an initial DNA dena-
turation step, followed by 40 cycles that included a dena-
turation step at 92°C for 30 s, primer annealing at 62°C for
45 s, and DNA synthesis at 72°C for 45 s, with a final
extension of 7 min at 72°C. The resulting PCR product
contained the cloned insert together with a T7 promoter
sequence at its 5 end. After clean up of the PCR product
(PCR purification kit, Qiagen, Courtaboeuf, France) this
DNA was used as a template for an in vitro transcription
(MEGAscript kit, Ambion, Austin, TX). The resulting RNA
was DNase digested and nonincorporated nucleotides were
eliminated using a Chroma Spin-30 DEPC H20 Column
(Clontech, Palo Alto, CA). Size and purity of the synthe-
sized RNA were verified on a denaturating-PAGE gel. The
concentration of the in vitro transcript was determined by a
highly sensitive and specific Gene Quant II spectrophoto-
metric operation system as already described (Onanga et al.,
2002). Aliquots were stored at 80°C until use. Immedi-
ately before usage, one aliquot of RNA was thawed and
diluted in RNase free H2O and five dilutions of the RNA
were used as external standard in each experiment. The
sensitivity of the assay was 2  102 RNA copies/ml of
plasma.
Primate immunodeficiency viruses ELISA (PIV-ELISA)
Antibody titers to both gp36 and V3 peptide were mea-
sured using a PIV-ELISA, as previous described (Simon et
al., 2001). Twofold serial dilutions from 1/100 to 1/12,800
and from 1/100 to 1/43,200 were done for each sample
tested against gp36 and V3 peptide, respectively. The cutoff
was established at 0.1 o.d.
Flow cytometry analysis
To quantify lymphocyte subsets and examine lympho-
cyte activation in infected versus uninfected animals, a
variety of antibodies against cell-surface markers were used,
as summarized in Table 2. Samples from noninfected
(M5H, M2I, F12A3, F5J, F16C, F12A7, and F5I), and
infected (F17, F17D, M2C2, M12A4, and M10G) mandrills
were analyzed by flow cytometry.
One hundred microliters of EDTA-treated whole blood
was incubated in the dark with 5 l antibody for 30 min at
4°C. Red blood cells were lysed using a standard ammo-
nium chloride lysing solution. Cells were then washed twice
in phosphate-buffered saline (PBS) and resuspended in PBS
with 1% paraformaldehyde. Data were acquired using a
FACsCalibur flow cytometer (Immunocytometry System,
Becton Dickinson) and analyzed with Cell Quest software
(Immunocytometry System, Becton Dickinson).
Statistical analysis and data presentation
Flow cytometriy data were analyzed for significant dif-
ferences (P  0.05) using the Mann–Whitney test. Corre-
lations were calculated and expressed as the Spearman co-
efficient of correlation (rs). Data were displayed using the
box-and-whisker plot method (Fig. 1).
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Table 2
Antibody panel used for evaluating host immune dynamics in mandrills
chronically infected with SIVmnd-1
mAB-PEa
(clone, source)
mAB-FITCb
(clone, source)
Cell type defined
IgG1 (PN0639 ITc) Control
IgG1 (BDd) Control
IgG1 (BD) IgG1 (IT) Control
IgG1 (BD) IgG2a (BD) Control
CD20 (Leu-16 BD) B cells
CD4 (Leu-3a BD) CD3 (FN-18 BSe) T cells, T helper cells
CD8 (Leu-2a BD) CD3 (FN-18 BS) T cells, T cytotoxic cells
CD28 (Leu-28BD) CD4 (Leu-3 BD) Costimulatory T helper cells
CD28 (Leu-28BD) CD8 (Leu 2a BD) Costimulatory T cytotoxic cells
CD4 (Leu-3a BD) CD8 (Leu 2a BD) T helper, T cytotoxic cells
CD4 (Leu-3a BD) HLA-DR (BD) Activated MHC II CD4 cells
CD8 (Leu-2a BD) HLA-DR (BD) Activated MHC II CD8 cells
a Phycoerythrin (PE).
b Fluorescein isothiocyanate (FITC).
c ImmunoTech (IT).
d BioSource (BS).
e Becton Dickinson (BD).
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